Učitavanje...
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
Objective: To evaluate the efficacy of poly ADP ribose polymerase (PARP) inhibitors (PARPis) in breast and ovarian cancer with BRCA (BReast CAncer susceptibility gene) mutation (BRCAm). Methods: We conducted a meta-analysis of randomized controlled, phase II or III trials by searching of electronic...
Spremljeno u:
| Izdano u: | Aging (Albany NY) |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8034970/ https://ncbi.nlm.nih.gov/pubmed/33705352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202724 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|